CHP Merger Corp.

CHP Merger Corp.

CHPM

CHPMCHP Merger Corp. US flag

NASDAQ Capital Market

10.18

USD

-0.01

- -

CIK

0001785041

ISIN

US12558Y1064

CUSIP

12558Y106

Return %

Stock

S&P500

1Y

- -

26.53

3Y

- -

76.60

5Y

3.88

80.11

Use logarithmic scale

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Company Description

CEO: James T. Olsen
Sector: Financial Services
Industry: Shell Companies
Address: 25 Deforest Ave Ste 108 Summit NJ United States of America 07901
IPO Date: Nov 22, 2019
CIK: 0001785041
Website: concordhp.com
Similar Companies: HHG Capital Corporation (HHGC)
Andretti Acquisition Corp. (WNNR-UN)
Z-Work Acquisition Corp. (ZWRK)
Worldwide Webb Acquisition Corp. (WWACW)
GX Acquisition Corp. (GXGXU)
TortoiseEcofin Acquisition Corp. III (TRTL)
Business: CHP Merger Corp. (CHPM) operates as a blank check company, or special purpose acquisition company (SPAC), with no significant independent operations; it focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses primarily in the healthcare or healthcare-related industries in the United States. The company provides no core products or services beyond its SPAC structure, which facilitates public market access for target entities through standard SPAC vehicles including trust accounts funded by IPO proceeds, redeemable shares, and warrants; its target sectors encompass healthcare providers, medical technology, biotechnology, and related services. Incorporated in 2019 and headquartered in Summit, New Jersey, CHP Merger Corp. maintains a lean operational footprint with approximately three employees at IPO and trades on NASDAQ under the ticker CHPM, with a market capitalization around $266 million as of recent data. Geographically, it concentrates on U.S.-based opportunities without disclosed international operations or subsidiaries. In recent developments, a proposed reverse merger with Integrity Implants Inc. (later rebranded as Accelus), announced in late 2021 with an estimated pro-forma enterprise value of $482 million, was unanimously approved by boards but ultimately cancelled in April 2022; the company extended its business combination deadline multiple times, including to May 2022 via stockholder vote, received $8 million in funding from CHP Acquisition Holdings LLC in 2019 to support trust contributions, and faced delisting in April 2022 while remaining active in trading with no successful merger consummated to date.

Company News